Elutia Inc reports results for the quarter ended December 31 - Earnings Summary

• Elutia Inc ELUT.OQ reported a quarterly adjusted loss of 26 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -40 cents. The mean expectation of two analysts for the quarter was for a loss of 25 cents per share. Wall Street expected results to range from -30 cents to -20 cents per share.

• Revenue fell 6.9% to $5.47 million from a year ago; analysts expected $5.90 million.

• Elutia Inc's reported EPS for the quarter was a loss of 26 cents​.

• The company reported a quarterly loss of $9.06 million.

• Elutia Inc shares had fallen by 24.9% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 2% in the last three months.​

• In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the pharmaceuticals peer group is also "buy"

Wall Street's median 12-month price target for Elutia Inc is $9.00

This summary was machine generated from LSEG data March 6 at 10:01 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)